Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Cancer Female × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Pain, Postoperative 16 Lung Neoplasms 12 Neoplasms 11 Brain Neoplasms 10 Depression 6 Carcinoma, Hepatocellular 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Colonic Neoplasms 5 Stomach Neoplasms 4 Pain 4 Ovarian Neoplasms 4 Leiomyoma 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Multiple Myeloma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3 Agnosia 3

Interventions

Tamoxifen 3 pyrotinib 2 abemaciclib 2 Metformin 2 Exercise 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 palbociclib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03007381 2017-08-16

KANGAROO

Nova Scotia Health Authority

Phase 4 Withdrawn

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡